ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

ClinicalTrials.gov ID: NCT00337571

Public ClinicalTrials.gov record NCT00337571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Three Fixed Doses of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Study identification

NCT ID
NCT00337571
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
218 participants

Conditions and interventions

Interventions

  • Aripiprazole Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
May 31, 2008
Completion
May 31, 2008
Last update posted
May 12, 2026

2006 – 2008

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
31
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35294
Harmonex Neuroscience Dothan Alabama 36303
Southwest Autism Research And Resource Center Phoenix Arizona 85006
Clinical Innovations, Inc. Huntington Beach California 92647
University Of California-Davis Medical Center Sacramento California 95817
Stanford University School Of Medicine Stanford California 94305
The Children'S Hospital Aurora Colorado 80045
Marsella, Gregory Boca Raton Florida 33432
University Of Florida Gainesville Florida 32611
University Of South Florida Tampa Florida 33613
Institute For Behavioral Medicine Smyrna Georgia 30080
University Of Illinois At Chicago Chicago Illinois 60606
Cambridge Health Alliance Medford Massachusetts 02139
Ladders Clinic Wellesley Massachusetts 02481
Children'S Hospital Of Michigan Detroit Michigan 48201
Regions Hospital Saint Paul Minnesota 55101
Children'S Mercy Hospital Kansas City Missouri 64108
Munroe-Meyer Institute Omaha Nebraska 68198
North Shore - Long Island Jewish Health System Bethpage New York 11714
Seaver And New York Autism Center Of Excellence New York New York 10029
Richmond Behavioral Associates Staten Island New York 10312
Mission Hospitals Asheville North Carolina 28801
Duke Child And Family Study Center Durham North Carolina 27710
The Nisonger Center Columbus Ohio 43210
Cutting Edge Research Oklahoma City Oklahoma 73116
Western Psychiatric Institute And Clinic Pittsburgh Pennsylvania 15203
Dallas Pediatric Neurology Associates Dallas Texas 75230
Bayou City Research, Ltd. Houston Texas 77007
Children'S National Medical Center Fairfax Virginia 22031
Pacific Institute Of Medical Sciences Bothell Washington 98011
Children'S Hospital Of Wisconsin Milwaukee Wisconsin 53201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00337571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00337571 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →